Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III serelaxin in acute heart failure (Japan, RLX030)
jRCT2080222681Phase 3
- Sponsor
- Novartis
- Start
- Dec 2014
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Acute Heart Failure (AHF) comparing Serelaxin arm with Placebo arm (2 arms).
02
Drugs
serelaxin
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on jRCT2080222681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222681.